A Randomized Phase III Study of Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery Alone for Patients with High-Risk Retroperitoneal Sarcoma (STRASS2).
Jacob LambdinCarrie RyanStephanie GregoryKenneth CardonaJonathan M HernandezWinan J van HoudtAlessandro GronchiPublished in: Annals of surgical oncology (2023)
Keyphrases
- neoadjuvant chemotherapy
- phase iii
- minimally invasive
- coronary artery bypass
- locally advanced
- open label
- clinical trial
- lymph node
- sentinel lymph node
- surgical site infection
- randomized controlled trial
- phase ii
- early stage
- double blind
- squamous cell carcinoma
- acute coronary syndrome
- rectal cancer
- coronary artery disease
- radiation therapy